Table 3.
Fatal cases (n = 66) of laboratory-confirmed COVID -19 cases, as of March 12th 2020, Republic of Korea.
| Variables | n | (%) |
|---|---|---|
| Age (y), median (range) | 77 | (35–93) |
|
| ||
| Sex | ||
| Female | 29 | (43.9) |
| Male | 37 | (56.1) |
|
| ||
| Coexisting condition* | ||
| Any | 61 | (96.8) |
| Cerebrovascular disease | 5 | (7.9) |
| Heart disease | 10 | (15.9) |
| Pulmonary disease | 11 | (17.5) |
| Kidney disease | 5 | (7.9) |
| Diabetes | 23 | (36.5) |
| Hypertension | 30 | (47.6) |
| Cancer | 7 | (11.1) |
| Neurodegenerative disorder | 16 | (25.4) |
| Under investigation | 5 | (6.5) |
|
| ||
| Region | ||
| Daegu | 47 | (71.2) |
| Gyeongbuk | 16 | (24.2) |
| Others | 3 | (4.5) |
|
| ||
| Death while in home | 5 | (7.6) |
| Diagnosis after death | 11 | (16.7) |
| Interval, days, median (range) | ||
| Symptom → Death | 10 | (1–24) |
| Symptom → Diagnosis | 4 | (0–20) |
| Symptom → Hospitalization | 4.5 | (0–11) |
| Hospitalization → Death | 5 | (0–16) |
| Total | 66 | |
*
A single case may have multiple comorbidities (investigation files required).